Is the clock ticking on Moderna's patent promise? Activists fear South African patents could hinder vaccine production

Citing its commitment to equitable vaccine access, Moderna pledged early on that it wouldn’t enforce its Covid-related IP rights while the pandemic is ongoing. But with talks of an endemic phase approaching, some worry South African patents will prevent a new manufacturer from producing much-needed shots.